Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative PRPH - ProPhase Labs, Inc.
34.5 M
LAST VALUE
23.85%
2 YEAR CAGR
41.81%
5 YEAR CAGR
8.38%
10 YEAR CAGR